Dr. Rogerio Lobo, MD

Dr. Lobo practices at Trustees of Columbia University in the City of New York in Fort Lee, New Jersey.

Dr. Lobo's NPI, 1578624466, was assigned on December 13, 2006. Dr. Lobo graduated from Georgetown University School Of Medicine in 1974. Dr. Lobo holds New York license 198859.

Dr. Lobo's primary practice is Trustees of Columbia University in the City of New York, at 400 Kelby St, Fort Lee, NJ 07024 in Bergen County. The practice phone is (646) 317-7111.

Dr. Lobo's primary practice is Trustees of Columbia University in the City of New York in Fort Lee, New Jersey. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Lobo to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lobo practices, 2 sites in all. Vendor and product names are available with a free account.

Reproductive endocrinology is Dr. Lobo's primary specialty in the NPI Registry, under taxonomy code 207VE0102X. Dr. Lobo is board certified in obstetrics & gynecology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Lobo's licenses on file in 4 states: New York, California, Illinois and New Jersey.

Dmand AI lists menopause and ovarian cyst among the conditions Dr. Lobo treats.

CMS data shows 12 Medicare services from Dr. Lobo across 1 procedure code in 2021, for 17 Medicare patients. Medicare paid $576 for them. Every service was in an office.

CMS counts 17 Medicare patients who saw Dr. Lobo in 2024. The largest group is under 65, with 0 patients. 71% of them have high cholesterol. Their average risk score is 0.73, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lobo's median patient age at 42, with 91% women.

In 2020, Dr. Lobo wrote 22 Medicare Part D claims. They cover 2 drugs, with $5,314 in total drug cost. In 2019, CMS named 18 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Lobo for performance year 2024, reported through an alternative payment model (APM). Dr. Lobo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 217 papers to Dr. Lobo, published from 2005 to 2024. 2022 was the busiest year, with 5. The most frequent topics are Polycystic Ovary Syndrome, Androgens and Estrogen Replacement Therapy. Dr. Lobo has published most often in Fertil Steril. Dr. Lobo's most frequent co-authors are Mark Victor Sauer, MD, Marcelle I. Cedars, MD and Micheline Chu, MD.

Dmand AI links Dr. Lobo to 3 clinical trials. Conditions studied include Coronary Disease, Gynatresia and Polycystic Ovary Syndrome.

CMS Open Payments shows 20 general payments to Dr. Lobo from 6 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 90% of the total. AMAG Pharmaceuticals, Inc. paid the most, $8,433. It also lists 2 research payments totaling $490 in 2017.

Dmand AI lists 3 awards for Dr. Lobo.

Dr. Lobo graduated from Georgetown University School Of Medicine in 1974. Dr. Lobo is a member of American College of Obstetricians and Gynecologists.

Dr. Lobo is in network with 13 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.